Investor Presentation (Nasdaq: MRVI) November 2021 Sciences Forward looking statements and use of non-GAAP financial measures This presentation contains, and our officers and representatives may from time-to-time make, "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Investors are cautioned that statements in this presentation which are not strictly historical statements constitute forward-looking statements, includin ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q3 2021 Results Conference Call November 10, 2021 5:00 PM ET Company Participants Debra Hart - Senior Director, IR Carl Hull - CEO Kevin Herde - EVP, CFO Conference Call Participants Matt Sykes - Goldman Sachs Tejas Savant - Morgan Stanley Dan Arias - Stifel John Sourbeer - UBS Paul Knight - KeyBanc Matt Larew - William Blair Michael Ryskin - Bank of America Catherine Schulte - Baird Operator Good day, and thank you for standing by. Welcome to the Q3 2021 Ma ...

Q2 2021 Financial Results (Nasdaq: MRVI) August 10, 2021 eSciences Today's Agenda Welcome Deb Hart, Head of Investor Relations 01 Financial Results & Guidance Kevin Herde, Chief Financial Officer 02 Business Highlights & Update Carl Hull, Chief Executive Officer 03 04 Q&A Session Carl Hull, Chief Executive Officer Kevin Herde, Chief Financial Officer 2 Forward looking statements and use of non-GAAP financial measures This presentation contains, and our officers and representatives may from time-to-time make ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q2 2021 Earnings Conference Call August 10, 2021 5:00 PM ET Company Participants Deb Hart - IR Carl Hull - Chairman and CEO Kevin Herde - CFO Conference Call Participants Matt Sykes - Goldman Sachs Tejas Savant - Morgan Stanley Dan Arias - Stifel Matt Larew - William Blair Michael Ryskin - Bank of America Operator Ladies and gentlemen thank you for standing by and welcome to the Maravai Lifesciences Second quarter 2021 earnings conference call. At this time ...

Investor Presentation (Nasdaq: MRVI) May 2021 eSciences Forward looking statements and use of non-GAAP financial measures This presentation contains, and our officers and representatives may from time-to-time make, "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Investors are cautioned that statements in this presentation which are not strictly historical statements constitute forward-looking statements, including, w ...

Q1 2021 Financial Results (Nasdaq: MRVI) May 10, 2021 eSciences Today's Agenda Welcome Deb Hart, Head of Investor Relations 01 Financial Results & Guidance Kevin Herde, Chief Financial Officer 02 Business Highlights & Update Carl Hull, Chief Executive Officer 03 Q&A Session 04 2 Forward looking statements and use of non-GAAP financial measures This presentation contains, and our officers and representatives may from time-to-time make, "forward-looking statements" within the meaning of the safe harbor provis ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2021 Earnings Conference Call May 10, 2021 5:00 PM ET Company Participants Deb Hart - Investor Relations Carl Hull - Chairman and Chief Executive Officer Kevin Herde - Chief Financial Officer Conference Call Participants Tejas Savant - Morgan Stanley Matt Sykes - Goldman Sachs Brandon Couillard - Jefferies Matt Larew - William Blair Derik De Bruin - Bank of America Dan Brennan - UBS Operator Good day and thank you for standing by. Welcome to the Q1 2021 M ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q4 2020 Earnings Conference Call March 2, 2021 5:00 PM ET Company Participants Debra Hart - Senior Director, IR Carl Hull - Partner, Co-Founder, CEO Kevin Herde - VP, CFO Eric Tardif - Partner, Co-Founder, President Conference Call Participants Tejas Savant - Morgan Stanley Matthew Sykes - Goldman Sachs Brandon Couillard - Jefferies Matt Larew - William Blair Catherine Schulte - Baird Erin Wright - Credit Sussie Dan Brennan - UBS Michael Ryskin - Bank of Ame ...